FR2793412B1 - Formulations galeniques d'argatroban pour administration sous-cutanee - Google Patents

Formulations galeniques d'argatroban pour administration sous-cutanee

Info

Publication number
FR2793412B1
FR2793412B1 FR9905974A FR9905974A FR2793412B1 FR 2793412 B1 FR2793412 B1 FR 2793412B1 FR 9905974 A FR9905974 A FR 9905974A FR 9905974 A FR9905974 A FR 9905974A FR 2793412 B1 FR2793412 B1 FR 2793412B1
Authority
FR
France
Prior art keywords
argatroban
galenic
formulations
subcutaneous administration
subcutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9905974A
Other languages
English (en)
Other versions
FR2793412A1 (fr
Inventor
Benedicte Roger
Gareth Lewis
Frederic Andre
Alain Cuine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9905974A priority Critical patent/FR2793412B1/fr
Priority to PCT/EP2000/004881 priority patent/WO2000067772A1/fr
Priority to AU53980/00A priority patent/AU5398000A/en
Publication of FR2793412A1 publication Critical patent/FR2793412A1/fr
Application granted granted Critical
Publication of FR2793412B1 publication Critical patent/FR2793412B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR9905974A 1999-05-11 1999-05-11 Formulations galeniques d'argatroban pour administration sous-cutanee Expired - Fee Related FR2793412B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9905974A FR2793412B1 (fr) 1999-05-11 1999-05-11 Formulations galeniques d'argatroban pour administration sous-cutanee
PCT/EP2000/004881 WO2000067772A1 (fr) 1999-05-11 2000-05-09 Formulations galeniques d'argatroban a administrer par voie sous-cutanee
AU53980/00A AU5398000A (en) 1999-05-11 2000-05-09 Galenic formulations of argatroban for subcutaneous administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9905974A FR2793412B1 (fr) 1999-05-11 1999-05-11 Formulations galeniques d'argatroban pour administration sous-cutanee

Publications (2)

Publication Number Publication Date
FR2793412A1 FR2793412A1 (fr) 2000-11-17
FR2793412B1 true FR2793412B1 (fr) 2001-07-27

Family

ID=9545446

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9905974A Expired - Fee Related FR2793412B1 (fr) 1999-05-11 1999-05-11 Formulations galeniques d'argatroban pour administration sous-cutanee

Country Status (3)

Country Link
AU (1) AU5398000A (fr)
FR (1) FR2793412B1 (fr)
WO (1) WO2000067772A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7915290B2 (en) * 2008-02-29 2011-03-29 Baxter International Inc. Argatroban formulations and methods for making and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE177635T1 (de) * 1993-04-22 1999-04-15 Senju Pharma Co Wässrige arzneizubereitungen enthaltend argatroban und cyclodextrin oder coffein
FR2715566B1 (fr) * 1994-02-03 1996-03-08 Synthelabo Solutions aqueuses concentrées d'argatroban.

Also Published As

Publication number Publication date
WO2000067772A1 (fr) 2000-11-16
FR2793412A1 (fr) 2000-11-17
AU5398000A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
EE05123B1 (et) Antiprogestiinsete omadustega ravimite manustamise vahendid
HK1034183A1 (en) Galenic formulations of meloxicam for oral administration.
FR2797772B1 (fr) Moyen pour activer un dispositif d'administration par ionophorese
NO20020208D0 (no) Flytende sammensetninger for oral administrasjon
PL351526A1 (en) Pharmaceutical formulation comprising amoxycillin
DE60016271D1 (de) Medikamentenzuführvorrichtung
FR2806918B1 (fr) Catheter pour l'administration specifique d'un medicament
HUP0201637A3 (en) Novel preparation and administration form comprising an acid-labile active compound
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
NO20015670L (no) Forbedrede farmasöytiske formuleringer
ITRM20010226A1 (it) Dispositivo impiantabile di altezza ridotta per la somministrazione di preparati medicinali.
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
FR2796287B1 (fr) Dispositif d'administration de medicament
HUP0203903A3 (en) Solubilized pharmaceutical composition for parenteral administration and its use
HK1045102A1 (zh) 藥物配方
HUP0201667A3 (en) Oral form of administration
FR2793412B1 (fr) Formulations galeniques d'argatroban pour administration sous-cutanee
ITMI20001848A0 (it) Faramaci per l'incontinenza.
FR2793418B1 (fr) Formulations galeniques d'agents antithrombotiques pour administration sous-cutanee
GB9902227D0 (en) Pharmaceutical composition for topical administration
GB9906126D0 (en) Pharmaceutical formulations
GB9930578D0 (en) Pharmaceutical formulations
ITMI992320A0 (it) Apparecchiatura per l'inoculazione di medicamenti in animali
FR2788544B1 (fr) Elements d'habillage pour poteau, notamment poteau de lampadaire
ITTO990393A0 (it) Apparecchio per infusione prolungata di farmaci

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse